News 2024 News MENU 2024 2023 2022 2021 2020 2019 2018 2017 2016 All Topics Press Release IR May 9, 2024 IR Consolidated Financial Results for the Year Ended March 31, 2024 [PDF:209.2 KB] May 9, 2024 IR Fiscal Year ended March 2024 Consolidated Financial Results [PDF:2.2 MB] May 9, 2024 IR Notice Concerning Change in Shareholder Return Policy (DOE index introduction) [PDF:59.1 KB] May 9, 2024 IR Notice Concerning Cancellation of Treasury Shares [PDF:44.2 KB] May 9, 2024 IR Notice Regarding Revision of Restricted Stock Compensation Plan [PDF:60.5 KB] Apr. 15, 2024 Press Release Lecture by Prof. Satoshi Uchida, Tokyo Medical and Dental University at the World Vaccine Congress 2024, USA Research on mRNA vaccines using DAICEL's "Actranza® lab." Apr. 10, 2024 Press Release DAICEL and ITRI Sign Partnership Agreement to Support Startups Mar. 28, 2024 Topics <ALERT> Please be aware of suspicious emails and documents attempting to deceive recipients by impersonating Daicel executives/employees [PDF:108.6 KB] Mar. 26, 2024 IR Notice Concerning the Status and Completion of Acquisition of Treasury Stocks [PDF:60.6 KB] Mar. 19, 2024 Topics Notification of Establishment of Joint Venture by Daicel Corporation and Inabata & Co., Ltd. Mar. 4, 2024 IR Notice Concerning the Status of acquisition of Treasury Stocks [PDF:59.5 KB] Feb. 26, 2024 IR Notice Concerning Change in Major Shareholders [PDF:66.5 KB] Feb. 19, 2024 Press Release Transfer of Daicel Pyrotechnics LTD. to Sightron Japan Inc. Feb. 6, 2024 IR 3rd Quarter Consolidated Financial Results for the Year Ending March 31, 2024 [PDF:134.1 KB] Feb. 6, 2024 IR 3rd Quarter of Fiscal Year ending March 2024 Consolidated Financial Results [PDF:865.9 KB] Feb. 2, 2024 IR Notice Concerning the Status of acquisition of Treasury Stocks [PDF:59.2 KB] Jan. 5, 2024 IR Notice Concerning the Status of acquisition of Treasury Stocks [PDF:58.8 KB]
May 9, 2024 IR Notice Concerning Change in Shareholder Return Policy (DOE index introduction) [PDF:59.1 KB]
Apr. 15, 2024 Press Release Lecture by Prof. Satoshi Uchida, Tokyo Medical and Dental University at the World Vaccine Congress 2024, USA Research on mRNA vaccines using DAICEL's "Actranza® lab."
Mar. 28, 2024 Topics <ALERT> Please be aware of suspicious emails and documents attempting to deceive recipients by impersonating Daicel executives/employees [PDF:108.6 KB]
Mar. 26, 2024 IR Notice Concerning the Status and Completion of Acquisition of Treasury Stocks [PDF:60.6 KB]
Mar. 19, 2024 Topics Notification of Establishment of Joint Venture by Daicel Corporation and Inabata & Co., Ltd.
Feb. 6, 2024 IR 3rd Quarter Consolidated Financial Results for the Year Ending March 31, 2024 [PDF:134.1 KB]
Feb. 6, 2024 IR 3rd Quarter of Fiscal Year ending March 2024 Consolidated Financial Results [PDF:865.9 KB]